There are 13,759 papers on cardiovascular disease in aging research: 723 trials and 7,518 observational studies in people, 144 in animals, 9 in cells, 4,777 reviews. The newest story, Nov 19, 2026: “Liver risk scores linked to dementia, cancer and death”.
“a primary cardiovascular event had occurred in 297 participants (10.9 events per 1000 person-years) in the atorvastatin group and in 412 participants (15.5 events per 1000 person-years) in the placebo group”
Physical activity is linked with less cardiovascular disease in humans (comparing 95th to 5th percentile of total activity) (TR=1.56, 95%CI:1.28-1.82).
“increased protective association of total physical activity after SIMEX correction (Time Ratio [TR]=1.56, 95%CI:1.28-1.82 vs. TR=1.38, 95%CI:1.24-1.54”
Humanscomparing 95th to 5th percentile of total activity
Bilateral salpingo-oophorectomy was not clearly linked with cardiovascular disease in humans (Non-malignant hysterectomy; compared with ovarian conservation) (HR 0.99, 95% CI 0.88-1.12).
“BSO was not associated with cardiovascular disease (50-54y: HR 0.99, 95% CI 0.88-1.12, p=0.85; ≥55y: HR 0.96, 95% CI 0.86-1.08, p=0.50)”
HumansNon-malignant hysterectomy; compared with ovarian conservationfemales
Incretin mimetics protect against cardiovascular disease in older patients with type 2 diabetes.
“Incretin mimetics also offer cardiovascular benefits in older patients with type 2 diabetes (T2DM) with potential benefits of replacing other anti-diabetes agents and reducing polypharmacy.”
Retinal ai-guided pre-screening triage strategy was not clearly linked with cardiovascular disease in humans (non-inferiority compared to standard safe cohort) (hazard ratio 1.08; 95% confidence interval 0.95-1.21).
“The Cox proportional hazards model confirmed no significant difference in CVD risk between the Retinal AI-guided and standard safe cohorts (hazard ratio 1.08; 95% confidence interval 0.95-1.21; p=0.245).”
Humansnon-inferiority compared to standard safe cohortmedian 10.0 yearsn = 40,850
Cardiovascular disease is linked with lower non-failing homeostatic LEC state in humans.
“Cardiovascular diseases showed a distinct trajectory, with depletion of a non-failing homeostatic state and expansion of shared and disease-associated remodeling states.”
Cardiovascular disease is linked with lower transfer entropy in patients with CVD (85.4 ± 0.8 mnats vs 87.9 ± 0.5 mnats (p < 0.001)).
“Our results indicate a significantly ( p < 0.001 ) lower TE in patients with CVD ( 85.4 ± 0.8 mnats) than that in healthy controls ( 87.9 ± 0.5 mnats)”
Cardiovascular disease is linked with higher depressive symptoms score in humans (around the time of CVD diagnosis) (pooled β: 0.089 SD [0.060-0.118]).
“A significant increase in depressive symptoms scores was observed around the time of CVD diagnosis (pooled β: 0.089 SD [0.060-0.118]).”
Posttraumatic stress disorder was not clearly linked with cardiovascular disease in humans (Women Veterans; multivariable-adjusted analysis) (OR 0.98, 95% CI 0.82–1.17; p = 0.82).
“PTSD was not a statistically significant independent predictor of CVD (OR = 0.98, 95% CI = 0.82-1.17, p = 0.82).”
Diabetes mellitus is linked with cardiovascular disease in humans (Mediation of the association between eGFRdiff and cardiovascular disease) (48.3% mediated).
“Diabetes significantly mediated 48.3% of the associations between eGFRdiff and cardiovascular disease.”
HumansMediation of the association between eGFRdiff and cardiovascular diseaseMedian follow-up of 5.0 yearsBoths
Frailty proteomic signature is linked with cardiovascular disease in humans (mediating the relationship between physical frailty and CVD) (proportion mediated: 49.18% (42.73%–53.40%)).
“Mediation analyses revealed that the proteomic signature of physical frailty [natural indirect effect: 1.14 (1.12–1.15), proportion mediated: 49.18% (42.73%–53.40%)] and identified hub proteins (e.g., TNF, IL-1β, IL6) partially mediated the relationship between physical frailty and CVD.”
Humansmediating the relationship between physical frailty and CVDn = 468,801
TRL/Lp(a)-linked chemokine signature is linked with cardiovascular disease in humans (TRL/remnant cholesterol–cardiovascular disease association) (Around 40% of the association, with wide confidence limits).
“A specific chemokine signature linked to both TRL and Lp(a) accounted for around 40% (with wide confidence limits) of the TRL/remnant cholesterol: cardiovascular disease (CVD) association.”
Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans.
“there was a significant association of high CHG_TWA/TyG_TWA with the risk of CVD, with these associations being stronger with longer exposure duration to high TyG index and CHG index”
Therapeutic advances in endocrinology and metabolism·
Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in people living with HIV-1 infection, highest vs lowest tertile (aHR 3.31, 95% CI 1.10-9.97).
“PWH in the highest TyG tertile had also higher risk for CVEs compared with those in the lowest tertile (aHR 3.31, 95% CI 1.10-9.97).”
Humansin people living with HIV-1 infection, highest vs lowest tertilemedian follow-up of 14.2 yearsn = 477
Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans among participants who reverted to normoglycaemia (adjusted HRs 1.89-2.52).
“Among participants who reverted to normoglycaemia, high cumulative TyG-derived indices were significantly associated with higher CVD risk (adjusted HRs 1.89-2.52; all p < 0.05).”
Humansamong participants who reverted to normoglycaemiamedian 5.0-year follow-up
Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans (highest TyG quartile compared to lowest) (HR 2.073, 95% CI 1.233 to 3.488).
“The highest TyG quartile was significantly associated with higher risks of CVD (HR = 2.073; 95% CI: 1.233 to 3.488)”
Obesity is associated with cardiovascular disease in humans (Community-dwelling adults in Amasya, Türkiye; adjusted for age and sex) (aOR 2.29, 95% CI 2.05–2.56).
“cardiovascular disease (aOR = 2.29, 95% CI 2.05-2.56)”
HumansCommunity-dwelling adults in Amasya, Türkiye; adjusted for age and sexBoth; 50.6% womensn = 22,667
Obesity is linked with a higher risk of cardiovascular disease in younger adults.
“Over a median follow-up of 4.5 years, the metabolic factors exhibited strong associations with incident CVD in younger adults which gradually attenuated with advancing age.”
Humansin younger adultsmedian follow-up of 4.5 years
Obesity is linked with a higher risk of cardiovascular disease in premenopausal women without MASLD (aHR 1.10, 95% CI 1.04-1.17).
“Among women without MASLD, general obesity was associated with risk before menopause (adjusted hazard ratio [aHR] 1.10, 95% confidence interval [CI] 1.04-1.17”
Obesity is linked with a higher risk of cardiovascular disease in humans (BMI-based persistent obesity) (aHR 1.31, 95% CI 1.20-1.44).
“persistent obesity was the only obesity-status trajectory associated with higher CVD risk (adjusted hazard ratio (aHR) 1.31, 95% confidence interval (CI) 1.20-1.44).”
Obesity is associated with cardiovascular disease in middle-aged (31-60 years) PWH at ART initiation (composite outcome of CVD/cancer/death) (aHR 1.49 [95% CI 1.11, 2.00]).
“middle aged (aHR 1.49 [95% CI 1.11, 2.00]) and older (aHR 1.20 [95% CI 0.60, 2.41]).”
Humansin middle-aged (31-60 years) PWH at ART initiation (composite outcome of CVD/cancer/death)
Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·
Obesity raises the risk of cardiovascular disease in humans.
“Obesity prevalence has increased drastically over the last three decades, contributing to disability, lower life expectancy, and higher risk of CVD”
Obesity raises the risk of cardiovascular disease in humans.
“excess prepregnancy weight, which has been associated with a higher risk of adverse maternal and fetal outcomes, including hypertension-related disorders, gestational diabetes, preeclampsia, and long-term cardiovascular complications”
Expert review of pharmacoeconomics & outcomes research·
Hypertension is linked with a higher risk of cardiovascular disease in humans (youngest group) (HR 3.60).
“In particular, the HR for hypertension declined from 3.60 in the youngest group to 2.12 in the middle-aged group, 1.41 in the older group, and 1.21 in the very old (≥80 years).”
Hypertension is linked with a higher risk of cardiovascular disease in humans (low 10-year/high 30-year predicted risk group) (57.8% (95% CI, 45.1%-70.0%)).
“Hypertension was the leading contributor to CVD events among participants with low 10-year/high 30-year predicted risk, accounting for 57.8% (95% CI, 45.1%-70.0%) of events in women”
Hypertension is linked with a higher risk of cardiovascular disease in humans (compared with normal BP) (HR 1.20, 95% CI 1.17-1.24).
“Compared with normal BP, the HRs were 1.03 (95% CI 1.00-1.07) for elevated BP, 1.08 (1.05-1.11) for stage 1 hypertension, and 1.20 (1.17-1.24) for stage 2 hypertension.”
Hypertension is linked with a higher risk of cardiovascular disease in humans (alone, compared with intact IC and no hypertension) (HR 1.68, 95% CI 1.46-1.93).
“hypertension alone (HR 1.68, 95% CI 1.46-1.93) were associated with higher CVD risk”
Humansalone, compared with intact IC and no hypertension
Hypertensive disorders of pregnancy raises the risk of cardiovascular disease in humans.
“Hypertensive disorders of pregnancy (HDP) affect approximately 1 in 7 pregnancies in the United States and are increasingly recognized as early and independent markers of lifetime cardiovascular disease.”
Hypertensive disorders of pregnancy raises the risk of cardiovascular disease in humans.
“Women with pregnancies complicated by hypertensive disorders of pregnancy (HDP) are at significantly increased risk of cardiovascular (CVD) and metabolic diseases.”
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·
Smoking is associated with cardiovascular disease in humans (Participants with COPD; smokers compared with never smokers).
“women with COPD who smoke remain at higher risk for CVD than their never-smoking counterparts.”
HumansParticipants with COPD; smokers compared with never smokersMedian follow-up of 10 yearsfemales
Smoking is associated with cardiovascular disease in humans (HR = 0.68, 95% CI = 0.49-0.97).
“The associations between composite lifestyles and CVDs were mainly driven by body mass index (HR = 0.47, 95% CI = 0.34-0.65) and smoking (HR = 0.68, 95% CI = 0.49-0.97).”
Metabolic dysfunction-associated steatotic liver disease is linked with a higher risk of cardiovascular disease in individuals with chronic HBV infection (HR 1.98, 95% CI 1.49-2.63).
Metabolic dysfunction-associated steatotic liver disease is associated with cardiovascular disease in humans (Standardized total association β=0.182 (95% CI, 0.154–0.210)).
“The pooled standardized total association between MASLD and CVD was β=0.182 (95% CI, 0.154-0.210).”
Exercise is linked with a lower risk of cardiovascular disease in humans (patients with hypertension) (OR = 1.47 for lack of exercise, 95% CI: 1.07-1.78, P = .001).
“lack of regular exercise (OR = 1.47, 95% CI: 1.07-1.78, P = .001)”
Exercise is linked with a lower risk of cardiovascular disease in humans (transition from metabolic to cardiovascular-metabolic disease in CHARLS) (HR = 0.71, 95% CI 0.62–0.82).
“were most pronounced for cardiovascular onset and for the transition from metabolic to cardiovascular-metabolic disease (CHARLS: HR = 0.71, 95% CI 0.62–0.82; SHARE: HR = 0.80, 95% CI 0.71–0.89).”
Humanstransition from metabolic to cardiovascular-metabolic disease in CHARLSn = 19,533
Cardiovascular disease predicts mortality in humans (re-occurring claim three years before index death in adults with Down syndrome).
“The most influential predictors of mortality were any claim for dementia, any claim for pneumonia, re-occurring claim for cardiovascular disease three years before index death, and any claim for heart failure and epilepsy.”
Humansre-occurring claim three years before index death in adults with Down syndrome11 yearsn = 137,293
Atorvastatin lowers the risk of cardiovascular disease in humans (without clinical cardiovascular disease) (HR 0.70, 95% CI 0.61–0.82, P<0.001).
“a primary cardiovascular event had occurred in 297 participants (10.9 events per 1000 person-years) in the atorvastatin group and in 412 participants (15.5 events per 1000 person-years) in the placebo group”
Human trialwithout clinical cardiovascular disease40 mg once daily5.9 yearsn = 9,971
The highest versus lowest quarter of laboratory-based scores was linked to 5.57 times the dementia risk at any given time.The highest versus lowest quarter of laboratory-based scores was linked to 5.57 times the dementia risk at any given time.
The high-blood-sugar and urine-protein group was linked to the highest risk of death over time, estimated at 2.59 times that of adults at stages 0 or 1.The high-blood-sugar and urine-protein group was linked to the highest risk of death over time, estimated at 2.59 times that of adults at stages 0 or 1.